Pancreatitis-Associated Protein in Neonatal Screening for Cystic Fibrosis: Strengths and Weaknesses

Pancreatitis-Associated Protein in Neonatal Screening for Cystic Fibrosis: Strengths and Weaknesses

There are currently four countries and one local region in Europe that use PAP in their newborn screening programme. The first country to employ PAP at a national level was the Netherlands, which started using IRT/PAP/DNA/EGA in 2011. Germany followed in 2016 with a slightly different IRT/PAP/DNA st...

Full description

Bibliographic Details
Main Authors:	Olaf Sommerburg, Jutta Hammermann
Format:	Article
Language:	English
Published:	MDPI AG 2020-03-01
Series:	International Journal of Neonatal Screening
Subjects:	cystic fibrosis newborn screening biochemical screening pancreatitis associated protein immunoreactive trypsinogen
Online Access:	https://www.mdpi.com/2409-515X/6/2/28

Similar Items

Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor–Tezacaftor–Ivacaftor
by: Payal Patel, et al.
Published: (2023-02-01)

Neonatal Screening for Cystic Fibrosis in Hungary—First-Year Experiences
by: Andrea Xue, et al.
Published: (2023-08-01)

Neonatal screening for cystic fibrosis in São Paulo State, Brazil: a pilot study
by: R. Rodrigues, et al.
Published: (2009-10-01)

Missed Cystic Fibrosis Newborn Screening Cases due to Immunoreactive Trypsinogen Levels below Program Cutoffs: A National Survey of Risk Factors
by: Martin Kharrazi, et al.
Published: (2022-10-01)

Performance of a Three-Tier (IRT-DNA-IRT) Cystic Fibrosis Screening Algorithm in British Columbia
by: Graham Sinclair, et al.
Published: (2020-06-01)

Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice
by: J Kai, et al.
Published: (2009-11-01)

Investigating CFTR gene variations in patient groups with positive newborn screening test results and preliminary clinical diagnosis of cystic fibrosis in the eastern anatolia region of Turkey
by: Ayberk Turkyilmaz, et al.
Published: (2021-06-01)

The first five-year evaluation of cystic fibrosis neonatal screening program in São Paulo State, Brazil
by: Léa Maria Zanini Maciel, et al.
Published: (2020-10-01)

Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present
by: Matteo Botti, et al.
Published: (2021-01-01)

Initial Evaluation of Prospective and Parallel Assessments of Cystic Fibrosis Newborn Screening Protocols in Eastern Andalusia: IRT/IRT versus IRT/PAP/IRT
by: Ilham Sadik, et al.
Published: (2019-09-01)

Newborn Screening for Cystic Fibrosis: Infant and Laboratory Factors Affecting Successful Sweat Test Completion
by: Ambika Shenoy, et al.
Published: (2020-12-01)

Cribado neonatal de fibrosis quística: análisis y diferencias de los niveles de tripsina inmunorreactiva en recién nacidos con cribado positivo
by: Marta Arrudi-Moreno, et al.
Published: (2021-07-01)

The Impact of the CFTR Gene Discovery on Cystic Fibrosis Diagnosis, Counseling, and Preventive Therapy
by: Philip M. Farrell, et al.
Published: (2020-04-01)

Influence of Season, Storage Temperature and Time of Sample Collection in Pancreatitis-Associated Protein-Based Algorithms for Newborn Screening for Cystic Fibrosis
by: Pia Maier, et al.
Published: (2024-01-01)

Elevated newborn serum immunoreactive trypsinogen associated with a congenital pancreatic cyst
by: Fabio Botelho, et al.
Published: (2021-10-01)

Newborn Screening Program for Cystic Fibrosis in Cuba: Three Years’ Experience
by: Elisa M. Castells, et al.
Published: (2023-06-01)

Racially equitable diagnosis of cystic fibrosis using next-generation DNA sequencing: a case report
by: Bennett O. V. Shum, et al.
Published: (2021-03-01)

The Changing Face of Cystic Fibrosis and Its Implications for Screening
by: Lutz Naehrlich
Published: (2020-07-01)

Cystic Fibrosis Newborn Screening in Portugal: PAP Value in Populations with Stringent Rules for Genetic Studies
by: Ana Marcão, et al.
Published: (2018-06-01)

Molecular analysis of cystic fibrosis patients in Hungary: An update to the mutational spectrum
by: Ivády Gergely, et al.
Published: (2015-01-01)

Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis
by: Rachael E. Armstrong, et al.
Published: (2020-05-01)

Newborn Screening for Cystic Fibrosis in Russia: A Catalyst for Improved Care
by: Victoria Sherman, et al.
Published: (2020-04-01)

Five cases of missed cystic fibrosis heterozygous mutations identified after a positive newborn screen on a sibling
by: Khaleel Qussous, et al.
Published: (2022-01-01)

Cystic Fibrosis Cases Missed by Newborn Bloodspot Screening—Towards a Consistent Definition and Data Acquisition
by: Anne Munck, et al.
Published: (2023-11-01)

Case report: Cystic fibrosis with kwashiorkor: A rare presentation in the era of universal newborn screening
by: Annemarie G. Wolfe, et al.
Published: (2023-01-01)

History of Newborn Screening for Cystic Fibrosis—The Early Years
by: Georges Travert, et al.
Published: (2020-01-01)

Cystic fibrosis: when neonatal screening is unsatisfactory for early diagnosis
by: Carolina Godoy, et al.
Published: (2024-01-01)

Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis
by: Chee Y. Ooi, et al.
Published: (2019-10-01)

High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification
by: Scott Mastromatteo, et al.
Published: (2023-01-01)

A Public Dialogue to Inform the Use of Wider Genomic Testing When Used as Part of Newborn Screening to Identify Cystic Fibrosis
by: Suzannah Kinsella, et al.
Published: (2022-05-01)

International Approaches to Management of CFTR-Related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis
by: Jane Chudleigh, et al.
Published: (2022-01-01)

INFLUENCE OF NEONATAL SCREENING FOR CYSTIC FIBROSIS BY THE EXAMPLE OF PATIENTS OF THE MOSCOW REGION
by: V. D. Sherman, et al.
Published: (2017-11-01)

Clinical complications in children with false-negative results in cystic fibrosis newborn screening
by: Katarzyna Zybert, et al.
Published: (2022-07-01)

A Multicentre Italian Study on the Psychological Impact of an Inconclusive Cystic Fibrosis Diagnosis after Positive Neonatal Screening
by: Antonella Tosco, et al.
Published: (2023-01-01)

Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening
by: Joan Kathleen DeCelie-Germana, et al.
Published: (2023-07-01)

Clinical and Genotypical Features of False-Negative Patients in 26 Years of Cystic Fibrosis Neonatal Screening in Tuscany, Italy
by: Giovanni Taccetti, et al.
Published: (2020-07-01)

Two years of newborn screening for cystic fibrosis in North Macedonia: First experience
by: Fustik S, et al.
Published: (2021-07-01)

Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey
by: Sevcan Tug Bozdogan, et al.
Published: (2021-01-01)

Bicarbonate Transport in Cystic Fibrosis and Pancreatitis
by: Dora Angyal, et al.
Published: (2021-12-01)

Development of the Addenbrooke's MSK screening tool (AMST) for children and adolescents with cystic fibrosis
by: Kieren Lock, et al.
Published: (2024-02-01)